Nicholas Manuelpillai
Western Health(AU)Skin Health Institute(AU)
Publications by Year
Research Areas
Psoriasis: Treatment and Pathogenesis, Asthma and respiratory diseases, Malaria Research and Control, Systemic Lupus Erythematosus Research, Inflammatory mediators and NSAID effects
Most-Cited Works
- → Combination treatment with monoclonal antibodies: Secukinumab, benralizumab and dupilumab for the combined management of psoriasis and severe asthma(2021)19 cited
- → Characterization and pathological significance of monoclonal DNA-binding antibodies from mice with experimental malaria infection(1994)17 cited
- → Secukinumab treatment demonstrated high drug survival and sustained effectiveness in patients with severe chronic plaque psoriasis: 21‐month analysis in Australian routine clinical practice (SUSTAIN study)(2022)11 cited
- → Management of severe vulval lichen sclerosus with adalimumab(2022)5 cited
- → Real‐World Guselkumab Response and Drug Survival in Australian Patients With Psoriasis: Results From the Australasian Psoriasis Registry(2024)3 cited
- → Eight‐Year Experience of Hedgehog Pathway Inhibitors at Three Tertiary Referral Centres in the Australian State of Victoria(2025)1 cited
- → A rare case of bilateral symmetrical broad‐based acquired ungual fibrokeratomas(2024)
- → Isotretinoin prescribing and monitoring practices among Australian dermatologists measured against current guidelines, and identification of practice uncertainties(2021)
- → Successful Treatment of Spontaneous Generalised Keloids With Dupilumab: A Case Report(2025)
- → Australian consensus: Treatment goals for moderate to severe psoriasis in the era of targeted therapies – Considerations for paediatric patients(2024)